Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
暂无分享,去创建一个
D. Cunningham | E. Levine | R. Glynne-Jones | N. Davidson | D. Sebag‐Montefiore | P. Plowman | R. Grieve | H. Meadows | D. Hurman
[1] D. Ryan,et al. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. , 2010, International journal of radiation oncology, biology, physics.
[2] D. Hollywood,et al. Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC). , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] Keitaro Matsuo,et al. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] L. Petruzelka,et al. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. , 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[5] L. Collette,et al. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014). , 2009, European journal of cancer.
[6] J. Roeske,et al. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Luca Cozzi,et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] M. Tenhunen,et al. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] Charles R. Thomas,et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. , 2008, JAMA.
[10] J. Roeske,et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[11] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[12] Woo Sung Kim,et al. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. , 2003, International journal of radiation oncology, biology, physics.
[13] P. Romestaing,et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] F. Landoni,et al. Neoadjuvant Chemotherapy to Radiation and Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Cervix: A Review of the Recent Literature , 1998, Tumori.
[15] H. Bartelink,et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] R. James. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.
[17] N. Petrelli,et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] S. Lipsitz,et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. , 1996, International journal of radiation oncology, biology, physics.
[19] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[20] A. Markoe,et al. Hyperfractionated Radiation Therapy and Concurrent 5‐Fluorouracil, Cisplatin and Mitomycin‐C in Head and Neck Carcinoma A Pilot Study , 1992, American journal of clinical oncology.
[21] L. Twiggs,et al. Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project. , 1990, The Journal of reproductive medicine.
[22] J. Cooper,et al. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study. , 1990, Gynecologic oncology.
[23] T. Daniel,et al. Cisplatin, 5‐fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma , 1989, Cancer.